Presentations associated with adverse drug interactions
Working back from the presentation (hyperkalaemia, bleeding, rhabdomyolysis, arrhythmia, confusion, AKI) to the drug combination behind it, and the high-yield pairs the exam keeps returning to.
Tier 1Approach to a presentation
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- An interaction is a cause to look for in any new problem after a medicine change. Most present within days to weeks of starting, stopping or changing a dose.
- Two mechanisms explain nearly all of them: pharmacokinetic (one drug changes the level of another) and pharmacodynamic (two drugs push the same effect).
- Risk concentrates in older people, CKD, polypharmacy, acute illness, and drugs with a narrow therapeutic index (warfarin, digoxin, lithium, tacrolimus, methotrexate, phenytoin, colchicine).
Loading the rest of the note…
Finished reading?
Sources
- Australian Medicines Handbook (interactions and individual drug monographs)AU/NZAustralian Medicines Handbook Pty Ltd, 2026
- Therapeutic Guidelines: Prescribing in Special PopulationsAU/NZTherapeutic Guidelines Limited, 2026
- Database of Adverse Event Notifications (DAEN) and reporting adverse eventsAU/NZTherapeutic Goods Administration, 2026
- Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 1995;29:172-91Clinical Pharmacokinetics, 1995
- Colchicine (COLCRYS) US prescribing information: drug interactionsUS National Library of Medicine (DailyMed), 2026
- Antidote stocking recommendations (glucagon not routinely stocked because of limited effectiveness)AU/NZQueensland Poisons Information Centre, 2026
- Lapi F et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury. BMJ 2013;346:e8525BMJ, 2013
- Juurlink DN et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51New England Journal of Medicine, 2004
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Turnstile bot check on sign-in and signed-out feedback